Quarterly report · Q3
7745.TEDINET S100SUG2
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥44.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥59.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥42.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥5.2bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥4.7bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥5.3bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥7.6bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.9bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥5.3bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.9bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.6bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.6bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥69.5bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥69.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥68.1bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥34.1bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥36.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥35.4bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥32.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥30.9bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.0bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥132.3 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.99 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.33 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥128.43 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.97 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥132.17 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥201.14 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥128.31 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 50.8% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.2% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 97
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥18.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥18.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥1.7bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥3.3bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥266m |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥107m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥7.1bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.1bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥0 |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥427m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥5.7bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.7bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥1.9bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥292m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥288m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥6.1bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥306m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥452m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥452m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | −¥36m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥5.9bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥5.9bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥11m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥358m |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥14.2bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥12.2bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.0bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥490m |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥12.4bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.9bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥8.6bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥23.6bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥19.5bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥4.2bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥854m |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥31.8bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥17.2bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥14.6bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥21.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥21.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥1.9bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.7bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.4bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥352m |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥486m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.8bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥6.8bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥1m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥31m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.5bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥451m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥7.4bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥328m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥7.0bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥242m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥730m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥729m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥0 |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥102m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥13.8bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥11.0bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥541m |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥13.1bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.1bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.0bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.3bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥25.6bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥19.9bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥34.5bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥18.4bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥16.1bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 449
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02344-000JapanMeasuringInstrumentsReportableSegmentsMember | 490000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02344-000AmericaMeasuringInstrumentsReportableSegmentsMember | 107000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02344-000EuropeMeasuringInstrumentsReportableSegmentsMember | -36000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02344-000AsiaAndOceaniaMeasuringInstrumentsReportableSegmentsMember | 292000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02344-000MeasuringInstrumentsReportableSegmentsMember | 854000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -1681000000 | JPY |
| Operating income | CurrentYTDDuration | 5179000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-02-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第47期第３四半期(自 2023年10月１日 至 2023年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社Ａ＆Ｄホロンホールディングス | |
| Company name in english cover page | FilingDateInstant | A&D HOLON Holdings Company, Limited | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役執行役員社長 森 島 泰 信 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都豊島区東池袋三丁目23番14号(同所は登記上の本店所在地で実際の業務は「最寄りの連絡場所」で行っております。) | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当事項はありません。 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当事項はありません。 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)埼玉県北本市朝日一丁目243番地 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)(０４８) ５９３－１５９０ (代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役上席執行役員 高 橋 浩 二 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02344 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 77450 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社Ａ＆Ｄホロンホールディングス | |
| Filer name in english | FilingDateInstant | A&D HOLON Holdings Company, Limited | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Current period end date | FilingDateInstant | 2023-12-31 | |
| Type of current period | FilingDateInstant | Q3 | |
| Current fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-12-31 | |
| Previous fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |